FIELD: dermatology and immunology.
SUBSTANCE: treatment is effected using 9-cis-retinoic acid or pharmaceutically acceptable salts thereof, or hydrolysable esters for preparation of drug intended for treatment of indicated disease. Therapeutic forms both for topical and oral administration can optionally be utilized. In contrast to retinoids, 9-cis-retinoic acid ensures high efficiency in treating hand skin eczema.
EFFECT: increased treatment efficiency and ensured treatment safety.
10 cl, 2 tbl
Authors
Dates
2004-10-20—Published
1998-08-18—Filed